Fireworks and eye safety poll: Which injuries do ophthalmologists see most often?

Poll

A survey of fireworks-related injuries for ophthalmologists and retina specialists.

Fireworks and eye safety poll: Which injuries do ophthalmologists see most often?

Do you educate patients on the risks associated with fireworks?

Yes
No

How many fireworks-related ocular injuries do you treat per year?

None
1-5
6-10
11-20
21-30
31+
[@portabletext/react] Unknown block type "pollMultiChoice", specify a component for it in the `components.types` prop

Related Content: Retinal Surgery | Ophthalmology | Retina in 2020 and Beyond

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
EURETINA 2025: Peter Kiraly, PhD, describes how the Young Retina Specialists (YOURS) committee helps surgeons break into the vitreoretinal surgery space
At the 2025 EURETINA Congress, Prof Korobelnik delivered the Gisbert Richard Lecture, focusing on removal of intra-ocular foreign bodies and minimizing ocular trauma.
Related Content
The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

Christina Y. Weng, MD, MBA, FASRS;Tony Stefater, MD, PhD;Tommy Stryjewski, MD
September 16th 2025
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
September 16th 2025
Podcast
Cannabis may protect against postoperative proliferative vitreoretinopathy development

Cannabis may protect against postoperative proliferative vitreoretinopathy development

Lynda Charters
September 16th 2025
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
September 16th 2025
Podcast
Q&A: Vivienne S. Hau, MD, PhD, discusses racial and ethnic disparities in retinoblastoma treatment options

Q&A: Vivienne S. Hau, MD, PhD, discusses racial and ethnic disparities in retinoblastoma treatment options

Vivienne S. Hau, MD, PhD;Martin David Harp;Sydney M Crago
September 16th 2025
Article
Q&A: Danny A. Mammo, MD, on the associations between androgen exposure, PCOS, and transmasculine individuals with central serous chorioretinopathy

Q&A: Danny A. Mammo, MD, on the associations between androgen exposure, PCOS, and transmasculine individuals with central serous chorioretinopathy

Danny A. Mammo, MD;Martin David Harp;Sydney M Crago
September 16th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.